ABSTRACT We began a study about the three main causes of blindness in 1990, because their incidence and prevalence have not changed in the last forty years. Twelve years later we concluded that the main source of energy for the human retina is water, not ATP. And this is also true for the entire human body. Water is the main source of energy. The amazing capability of eukaryotic cells to break or dissociate the water molecule was unsuspected to us because it takes 2000℃ degrees to dissociate water in a laboratory environment, and until today, it was believed that only plants were capable of accomplishing this. Photosynthesis occurs in humans as it does in plants. The water that we drink every day is not just to wash away detritus and toxins; it is not just a cleaner, nor a simple solvent. When our body dissociates the water molecule, cells are able to get their energy from Hydrogen (Hydrogen is the energy carrier that Nature uses the most). Water is our main source of energy. If our body couldn’t acquire energy from water, we would need to eat between 50 - 170 kg (110 - 374 lbs) daily. In any system, when a generalized failure occurs, we must suspect energy first. Parkinson and Alzheimer’s Disease are examples of a generalized failure. That explains why it is not uncommon that patients improve dramatically with pharmacological stimulation of the human photosynthesis process. Recall that the brain needs energy not only to grow or to perform its functions, but also to preserve its form and shape. The best energy for human cells is Hydrogen.
Cite this paper
nullM. Arias-Esparza, R. Arias, P. Arias, M. Arias and A. Solís-Herrera, "The Unexpected Capability of Melanin to Split the Water Molecule and the Alzheimer’s Disease," Neuroscience and Medicine, Vol. 2 No. 3, 2011, pp. 217-221. doi: 10.4236/nm.2011.23029.
 I. Klyubin, V. Betts, A. T. Welzel, et al., “Amyloid Beta Protein Dimer-Containing Human CSF Disrupts Synaptic Plasticity: Prevention by Systemic Passive Immunization,” The Journal of Neuroscience, 2008, Vol. 28, No. 16, pp. 4231-4237.
L. F. Lue, Y. M. Kuo, A. E. Roher, et al., “Soluble Amyloid Beta Peptide Concentration as a Predictor of Synaptic Change in Alzheimer’s Disease,” The American Journal of Pathology, Vol. 155, No. 3, 1999, pp. 853-62.
F. Kamenetz, T. Tomita, H. Hsieh, et al., “APP Processing and Synaptic Function,” Neuron, Vol. 37, No. 6, 2003, pp. 925-937.
J. Carter and C. F. Lippa, “Beta-Amyloid, Neuronal Death and Alzheimer’s Disease,” Current Molecular Medicine, Vol. 1, No. 6, December 2001, pp. 733-737.
A. Solís-Herrera, M. de C. Arias-Esparza, R. I. Solís-Arias, P. E. Solís-Arias and M. P. Solís-Arias, “The Unexpected Capacity of Melanin to Dissociate the Water Molecule Fills the Gap Between the Life Before and After ATP,” Biomedical Research, Vol. 21, No. 2, 2010, pp. 224-226.
E. Dadachova, R. A. Bryan, O. C. Howell, “The Radioprotective Properties of Fungal Melanin Are a Function of Its Chemical Composition, Stable Radical Presence and Spatial Arrangement,” Pigment Cell & Melanoma Research, Vol. 21, No. 2, 2008pp. 192-199.
M. P. SolísArias, “The Unexpected Capacity of Melanin to Dissociaolecule Fills the Gap Between the Life Before and After ATP,” Biomedical Research, Vol. 21, No. 2, 2010, pp. 224-226.
A. Solís-Herrera, Ma del C. Arias-Esparza, et al., “The Pharmacologic Intensification of the Water Dissociation (Human Photosynthesis) and Its Effect over Tissues Affected by Bloodshed of Diverse Etiology, International Journal of Clinical Medicine, Vol. 2, No. 2, 2011, pp. .
E. Planel, A. Bretteville, L. Liu, et al., “Acceleration and Persistence of Neurofibrillary Pathology in a Mouse Model of Tauopathy Following Anesthesia,” The FASEB Journal, Vol. 23, No. 8, 2009, pp. 2595-2604.
Z. Xie, D. J. Culley, Y. Dong, et al., “The Common Inhalation Anesthetic Isoflurane Induces Caspase Activation and Increases Amyloid Beta-Protein Level in Vivo,” Annals of Neurology, Vol. 64, No. 6, 2008, pp. 618-267.
Z. Arvanitakis, R. S. Wilson, J. L. Bienias, D. A. Evans and D. A. Bennett, “Diabetes Mellitus and Risk of Alzheimer Disease and Decline in Cognitive Function,” Archives of Neurology, Vol. 61, No. 5, 2004, pp. 661-666.
M. A. Lovell, J. D. Robertson, W. J. Teesdale, J. L. Campbell, W. R. Markesbery, “Copper, Iron and Zinc in Alzheimer’s Disease Senile Plaques,” Journal of the Neurological Sciences, Vol. 158, No. 1, 1998, pp. 47-52.
W. Wu, A. M. Brickman, J. Luchsinger, et al., “The Brain in the Age of Old: The Hippocampal Formation Is Targeted Differentially by Diseases of Late Life,” Annals of Neurology, Vol. 64, No. 6, 2008, pp. 698-706.
R. Deane and B. V. Zlokovic, “Role of the Blood-Brain Barrier in the Pathogenesis of Alzheimer’s Disease,” Current Alzheimer Research, Vol. 4, No. 2, 2007, pp. 191-197.
P. F. Good, P. Werner, A. Hsu, C. W. Olanow and D. P. Perl, “Evidence of Neuronal Oxidative Damage in Alzheimer’s Disease,” The American Journal of Pathology, Vol. 149, No. 1, 1996, pp. 21-28.
A. Nunomura, G. Perry, G. Aliev, et al., “Oxidative Damage Is the Earliest Event in Alzheimer Disease,” Journal of Neuropathology & Experimental Neurology, Vol. 60, No. 7, 2001, pp. 59-67.
K. Hensley, J. M. Carney, M. P. Mattson, et al., “A Model for Beta-Amyloid Aggregation and Neurotoxicity Based on Free Radical Generation by the Peptide: Relevance to Alzheimer Disease,” Proceedings of the National Academy of Sciences of the U S A, Vol. 91, No. 8, 1994, pp. 3270-3274.
C. K. Combs, J. C. Karlo, S. C. Kao, G. E. Landreth, “Beta-Amy-Loid Stimulation of Microglia And Monocytes Results in TNFalpha-Dependent Expression of Inducible Nitric Oxide Synthase and Neuronal Apoptosis,” The Journal of Neuroscience, Vol. 21, No. 4, 2001, pp. 1179-1188.
A. Solis-Herrera, M. E.Lara, L. E. Rendón, “The Photoelectrochemical Properties of Melanin,” Nature Precedings: hdl:10101/npre.2007.1312.1